Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$159.51 /

-2.075 (-1.28%)

09:33
04/14/21
04/14
09:33
04/14/21
09:33

EMA says 'expediting' evaluation of Johnson & Johnson COVID-19 vaccine

The European Medicines Agency said that, as announced last week, EMA's safety committee, or PRAC, is reviewing very rare cases of unusual blood clots that occurred in the United States following the use of Janssen's COVID-19 vaccine. The type of blood clot reported, cerebral venous sinus thrombosis, occurred in most cases in combination with low levels of blood platelets, the EMA noted. "EMA is investigating all the cases reported and will decide whether regulatory action is necessary. The Agency is working closely with the US FDA and other international regulators. EMA is expediting this evaluation and currently expects to issue a recommendation next week. While its review is ongoing, EMA remains of the view that the benefits of the vaccine in preventing COVID-19 outweigh the risks of side effects. The Agency's scientific opinions provide EU Member States with the information they need to take decisions on the use of vaccines in their national vaccination campaigns," the EMA announced. Reference Link

  • 20

    Apr

  • 22

    Apr

JNJ Johnson & Johnson
$159.51 /

-2.075 (-1.28%)

04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause

TODAY'S FREE FLY STORIES

Earnings
Cooper Companies reports Q4 EPS $3.28, consensus $3.37 » 16:18
12/02/21
12/02
16:18
12/02/21
16:18
COO

Cooper Companies

$378.00 /

+3.93 (+1.05%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COO Cooper Companies
$378.00 /

+3.93 (+1.05%)

COO Cooper Companies
$378.00 /

+3.93 (+1.05%)

10/21/21 KeyBanc
Cooper Companies price target lowered to $465 from $476 at KeyBanc
09/03/21 Stifel
Cooper Companies price target raised to $475 from $450 at Stifel
09/03/21 Citi
Cooper Companies price target raised to $453 from $400 at Citi
09/03/21 Oppenheimer
Cooper Companies price target raised to $475 from $405 at Oppenheimer
COO Cooper Companies
$378.00 /

+3.93 (+1.05%)

COO Cooper Companies
$378.00 /

+3.93 (+1.05%)

Hot Stocks
Smith & Wesson Brands reports Q2 gross margin 44.3% vs. 40.6% last year » 16:18
12/02/21
12/02
16:18
12/02/21
16:18
SWBI

Smith & Wesson Brands

$22.94 /

+0.405 (+1.80%)

Deana McPherson,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

09/02/21 Lake Street
Smith & Wesson undervalued after 'another strong quarter,' says Lake Street
06/21/21 Lake Street
Smith & Wesson Brands price target raised to $43 from $34 at Lake Street
03/05/21
Fly Intel: Top five analyst downgrades
03/05/21 Lake Street
Smith & Wesson Brands price target raised to $34 from $28 at Lake Street
SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

Earnings
Yext reports Q3 non-GAAP EPS (4c), consensus (7c) » 16:17
12/02/21
12/02
16:17
12/02/21
16:17
YEXT

Yext

$9.41 /

+0.25 (+2.73%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
YEXT Yext
$9.41 /

+0.25 (+2.73%)

YEXT Yext
$9.41 /

+0.25 (+2.73%)

03/04/21
Fly Intel: Top five analyst downgrades
03/04/21 Truist
Yext price target lowered to $17 from $23 at Truist
03/04/21 William Blair
Yext downgraded to Market Perform on growth headwinds at William Blair
03/04/21 William Blair
Yext downgraded to Market Perform from Outperform at William Blair
YEXT Yext
$9.41 /

+0.25 (+2.73%)

YEXT Yext
$9.41 /

+0.25 (+2.73%)

YEXT Yext
$9.41 /

+0.25 (+2.73%)

Earnings
Asana sees FY22 EPS (96c)-(95c), consensus ($1.00) » 16:17
12/02/21
12/02
16:17
12/02/21
16:17
ASAN

Asana

$91.01 /

+1.05 (+1.17%)

Sees FY22 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASAN Asana
$91.01 /

+1.05 (+1.17%)

ASAN Asana
$91.01 /

+1.05 (+1.17%)

11/18/21 Piper Sandler
Asana price target raised to $140 from $85 at Piper Sandler
11/04/21 Jefferies
Asana downgraded to Hold from Buy at Jefferies
10/21/21 KeyBanc
Asana price target raised to $143 from $85 at KeyBanc
10/06/21 Jefferies
Asana CEO's share buys 'a great indicator' of momentum, says Jefferies
ASAN Asana
$91.01 /

+1.05 (+1.17%)

ASAN Asana
$91.01 /

+1.05 (+1.17%)

ASAN Asana
$91.01 /

+1.05 (+1.17%)

ASAN Asana
$91.01 /

+1.05 (+1.17%)

Earnings
Guidewire backs FY22 revenue view $780M-$790M, consensus $785.96M » 16:17
12/02/21
12/02
16:17
12/02/21
16:17
GWRE

Guidewire

$117.11 /

+3.88 (+3.43%)

Sees FY22 adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GWRE Guidewire
$117.11 /

+3.88 (+3.43%)

GWRE Guidewire
$117.11 /

+3.88 (+3.43%)

11/22/21 Barclays
Duck Creek Technologies upgraded to Overweight from Equal Weight at Barclays
10/04/21 BofA
Guidewire downgraded to Underperform from Neutral at BofA
09/03/21 JPMorgan
Guidewire price target raised to $160 from $145 at JPMorgan
09/03/21 BTIG
Guidewire price target raised to $138 from $130 at BTIG
GWRE Guidewire
$117.11 /

+3.88 (+3.43%)

GWRE Guidewire
$117.11 /

+3.88 (+3.43%)

GWRE Guidewire
$117.11 /

+3.88 (+3.43%)

Earnings
Ooma sees Q4 EPS 9c-11c, consensus 10c » 16:17
12/02/21
12/02
16:17
12/02/21
16:17
OOMA

Ooma

$19.05 /

+0.23 (+1.22%)

Sees Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OOMA Ooma
$19.05 /

+0.23 (+1.22%)

OOMA Ooma
$19.05 /

+0.23 (+1.22%)

09/03/21 B. Riley
Ooma price target raised to $27.50 from $24 at B. Riley
09/03/21 Benchmark
Ooma price target raised to $30 from $27 at Benchmark
09/03/21 JMP Securities
Ooma price target raised to $27 from $22 at JMP Securities
05/27/21 B. Riley
Ooma price target raised to $24 from $23.50 at B. Riley
OOMA Ooma
$19.05 /

+0.23 (+1.22%)

OOMA Ooma
$19.05 /

+0.23 (+1.22%)

Initiation
Vor Biopharma initiated with an Outperform at Baird » 16:17
12/02/21
12/02
16:17
12/02/21
16:17
VOR

Vor Biopharma

$13.08 /

+1.71 (+15.04%)

Baird analyst Jack Allen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VOR Vor Biopharma
$13.08 /

+1.71 (+15.04%)

VOR Vor Biopharma
$13.08 /

+1.71 (+15.04%)

12/01/21 Oppenheimer
Vor Biopharma initiated with an Outperform at Oppenheimer
10/19/21 JMP Securities
Vor Biopharma initiated with an Outperform at JMP Securities
07/08/21 Stifel
Vor Biopharma, Janssen collaboration benefits both parties, says Stifel
03/25/21 B. Riley Securities
Vor Biopharma initiated with a Buy at B. Riley Securities
VOR Vor Biopharma
$13.08 /

+1.71 (+15.04%)

  • 05
    Feb
Earnings
Guidewire sees Q2 revenue $195M-$199M, consensus $189.57M » 16:16
12/02/21
12/02
16:16
12/02/21
16:16
GWRE

Guidewire

$117.11 /

+3.88 (+3.43%)

Sees Q2 adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GWRE Guidewire
$117.11 /

+3.88 (+3.43%)

GWRE Guidewire
$117.11 /

+3.88 (+3.43%)

11/22/21 Barclays
Duck Creek Technologies upgraded to Overweight from Equal Weight at Barclays
10/04/21 BofA
Guidewire downgraded to Underperform from Neutral at BofA
09/03/21 JPMorgan
Guidewire price target raised to $160 from $145 at JPMorgan
09/03/21 BTIG
Guidewire price target raised to $138 from $130 at BTIG
GWRE Guidewire
$117.11 /

+3.88 (+3.43%)

GWRE Guidewire
$117.11 /

+3.88 (+3.43%)

GWRE Guidewire
$117.11 /

+3.88 (+3.43%)

Earnings
Ooma reports Q3 EPS 13c, consensus 9c » 16:16
12/02/21
12/02
16:16
12/02/21
16:16
OOMA

Ooma

$19.05 /

+0.23 (+1.22%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OOMA Ooma
$19.05 /

+0.23 (+1.22%)

OOMA Ooma
$19.05 /

+0.23 (+1.22%)

09/03/21 B. Riley
Ooma price target raised to $27.50 from $24 at B. Riley
09/03/21 Benchmark
Ooma price target raised to $30 from $27 at Benchmark
09/03/21 JMP Securities
Ooma price target raised to $27 from $22 at JMP Securities
05/27/21 B. Riley
Ooma price target raised to $24 from $23.50 at B. Riley
OOMA Ooma
$19.05 /

+0.23 (+1.22%)

OOMA Ooma
$19.05 /

+0.23 (+1.22%)

Earnings
Asana sees Q4 EPS (28c)-(27c), consensus (27c) » 16:16
12/02/21
12/02
16:16
12/02/21
16:16
ASAN

Asana

$91.01 /

+1.05 (+1.17%)

Sees Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASAN Asana
$91.01 /

+1.05 (+1.17%)

ASAN Asana
$91.01 /

+1.05 (+1.17%)

11/18/21 Piper Sandler
Asana price target raised to $140 from $85 at Piper Sandler
11/04/21 Jefferies
Asana downgraded to Hold from Buy at Jefferies
10/21/21 KeyBanc
Asana price target raised to $143 from $85 at KeyBanc
10/06/21 Jefferies
Asana CEO's share buys 'a great indicator' of momentum, says Jefferies
ASAN Asana
$91.01 /

+1.05 (+1.17%)

ASAN Asana
$91.01 /

+1.05 (+1.17%)

ASAN Asana
$91.01 /

+1.05 (+1.17%)

ASAN Asana
$91.01 /

+1.05 (+1.17%)

Initiation
ESS Inc. initiated with an Outperform at Oppenheimer » 16:16
12/02/21
12/02
16:16
12/02/21
16:16
GWH

ESS Inc.

$15.82 /

+0.24 (+1.54%)

Oppenheimer analyst Colin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GWH ESS Inc.
$15.82 /

+0.24 (+1.54%)

GWH ESS Inc.
$15.82 /

+0.24 (+1.54%)

11/30/21 Canaccord
ESS Inc. initiated with a Buy at Canaccord
11/01/21 Cowen
ESS Tech initiated with an Outperform at Cowen
10/21/21 Loop Capital
Loop starts 'energy transition' play ESS with Buy, $29 price target
10/21/21 Loop Capital
ESS Tech initiated with a Buy at Loop Capital
GWH ESS Inc.
$15.82 /

+0.24 (+1.54%)

Hot Stocks
Protagonist Therapeutics announces selection of PN-235 into Phase 2 development » 16:16
12/02/21
12/02
16:16
12/02/21
16:16
PTGX

Protagonist Therapeutics

$32.67 /

+1.67 (+5.39%)

, JNJ

Johnson & Johnson

$157.08 /

-1.06 (-0.67%)

Protagonist Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PTGX Protagonist Therapeutics
$32.67 /

+1.67 (+5.39%)

JNJ Johnson & Johnson
$157.08 /

-1.06 (-0.67%)

PTGX Protagonist Therapeutics
$32.67 /

+1.67 (+5.39%)

11/15/21 JMP Securities
Protagonist Therapeutics price target raised to $70 from $60 at JMP Securities
11/04/21 Piper Sandler
Piper 'pleasantly surprised' by Protagonist Therapeutics' ASH abstracts
10/13/21 JMP Securities
Protagonist Therapeutics price target raised to $60 from $47 at JMP Securities
10/12/21 JPMorgan
JPMorgan upgrades Protagonist after 'rapid' clinical hold removal
JNJ Johnson & Johnson
$157.08 /

-1.06 (-0.67%)

11/29/21 Credit Suisse
Credit Suisse stays Outperform on J&J as intra-quarter checks find pharma upside
11/09/21 Mizuho
Alkermes price target lowered to $33 from $36 at Mizuho
11/08/21 Morgan Stanley
Morgan Stanley bullish on 2seventy Bio, initiates with an Overweight
10/20/21 Raymond James
Johnson & Johnson price target lowered to $178 from $183 at Raymond James
PTGX Protagonist Therapeutics
$32.67 /

+1.67 (+5.39%)

JNJ Johnson & Johnson
$157.08 /

-1.06 (-0.67%)

  • 16
    Jun
  • 11
    Dec
JNJ Johnson & Johnson
$157.08 /

-1.06 (-0.67%)

PTGX Protagonist Therapeutics
$32.67 /

+1.67 (+5.39%)

JNJ Johnson & Johnson
$157.08 /

-1.06 (-0.67%)

PTGX Protagonist Therapeutics
$32.67 /

+1.67 (+5.39%)

JNJ Johnson & Johnson
$157.08 /

-1.06 (-0.67%)

Earnings
Guidewire reports Q1 adjusted EPS (21c), consensus (25c) » 16:16
12/02/21
12/02
16:16
12/02/21
16:16
GWRE

Guidewire

$117.11 /

+3.88 (+3.43%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GWRE Guidewire
$117.11 /

+3.88 (+3.43%)

GWRE Guidewire
$117.11 /

+3.88 (+3.43%)

11/22/21 Barclays
Duck Creek Technologies upgraded to Overweight from Equal Weight at Barclays
10/04/21 BofA
Guidewire downgraded to Underperform from Neutral at BofA
09/03/21 JPMorgan
Guidewire price target raised to $160 from $145 at JPMorgan
09/03/21 BTIG
Guidewire price target raised to $138 from $130 at BTIG
GWRE Guidewire
$117.11 /

+3.88 (+3.43%)

GWRE Guidewire
$117.11 /

+3.88 (+3.43%)

GWRE Guidewire
$117.11 /

+3.88 (+3.43%)

Earnings
Asana reports Q3 EPS (23c), consensus (26c) » 16:15
12/02/21
12/02
16:15
12/02/21
16:15
ASAN

Asana

$91.01 /

+1.05 (+1.17%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASAN Asana
$91.01 /

+1.05 (+1.17%)

ASAN Asana
$91.01 /

+1.05 (+1.17%)

11/18/21 Piper Sandler
Asana price target raised to $140 from $85 at Piper Sandler
11/04/21 Jefferies
Asana downgraded to Hold from Buy at Jefferies
10/21/21 KeyBanc
Asana price target raised to $143 from $85 at KeyBanc
10/06/21 Jefferies
Asana CEO's share buys 'a great indicator' of momentum, says Jefferies
ASAN Asana
$91.01 /

+1.05 (+1.17%)

ASAN Asana
$91.01 /

+1.05 (+1.17%)

ASAN Asana
$91.01 /

+1.05 (+1.17%)

ASAN Asana
$91.01 /

+1.05 (+1.17%)

Initiation
Ecolab resumed with an In Line at Evercore ISI » 16:15
12/02/21
12/02
16:15
12/02/21
16:15
ECL

Ecolab

$224.52 /

+4.18 (+1.90%)

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ECL Ecolab
$224.52 /

+4.18 (+1.90%)

ECL Ecolab
$224.52 /

+4.18 (+1.90%)

10/27/21
Fly Intel: Top five analyst downgrades
10/27/21 BMO Capital
Ecolab price target raised to $246 from $223 at BMO Capital
10/27/21 JPMorgan
Ecolab downgraded to Underweight on valuation at JPMorgan
10/27/21 Deutsche Bank
Ecolab price target raised to $260 from $250 at Deutsche Bank
ECL Ecolab
$224.52 /

+4.18 (+1.90%)

ECL Ecolab
$224.52 /

+4.18 (+1.90%)

Hot Stocks
Zillow approves $750M share repurchase program » 16:15
12/02/21
12/02
16:15
12/02/21
16:15
Z

Zillow

$54.30 /

+1.255 (+2.37%)

Zillow Group authorized…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
Z Zillow
$54.30 /

+1.255 (+2.37%)

Z Zillow
$54.30 /

+1.255 (+2.37%)

11/22/21 Piper Sandler
October housing data positive for Redfin and Zillow, says Piper Sandler
11/19/21 Piper Sandler
Zillow Group price target lowered to $68 from $78 at Piper Sandler
11/04/21 Citi
Citi downgrades Zillow with shares in 'penalty box' on homes exit
11/03/21 Craig-Hallum
Zillow Group price target lowered to $95 from $135 at Craig-Hallum
Z Zillow
$54.30 /

+1.255 (+2.37%)

Z Zillow
$54.30 /

+1.255 (+2.37%)

Z Zillow
$54.30 /

+1.255 (+2.37%)

Z Zillow
$54.30 /

+1.255 (+2.37%)

Syndicate
AppLovin announces launch of 6.5M shares of Class A common stock » 16:15
12/02/21
12/02
16:15
12/02/21
16:15
APP

AppLovin

$90.37 /

+4.09 (+4.74%)

AppLovin Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APP AppLovin
$90.37 /

+4.09 (+4.74%)

APP AppLovin
$90.37 /

+4.09 (+4.74%)

11/18/21
Fly Intel: Top five analyst initiations
11/18/21 Arete
AppLovin initiated with a Sell at Arete
11/12/21 Stifel
AppLovin price target raised to $125 from $110 at Stifel
11/11/21 Truist
AppLovin price target raised to $110 from $100 at Truist
APP AppLovin
$90.37 /

+4.09 (+4.74%)

  • 15
    Apr
APP AppLovin
$90.37 /

+4.09 (+4.74%)

Hot Stocks
Lyell Immunopharma announces return of Dr. Rick Klausner as board chair » 16:14
12/02/21
12/02
16:14
12/02/21
16:14
LYEL

Lyell Immunopharma

$9.46 /

+0.09 (+0.96%)

Lyell Immunopharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LYEL Lyell Immunopharma
$9.46 /

+0.09 (+0.96%)

07/12/21 JPMorgan
Lyell Immunopharma initiated with an Overweight at JPMorgan
07/12/21 Morgan Stanley
Lyell Immunopharma initiated with an Overweight at Morgan Stanley
07/12/21 BofA
Lyell Immunopharma initiated with a Buy at BofA
07/12/21 Goldman Sachs
Lyell Immunopharma initiated with a Buy at Goldman Sachs
LYEL Lyell Immunopharma
$9.46 /

+0.09 (+0.96%)

  • 17
    Jun
LYEL Lyell Immunopharma
$9.46 /

+0.09 (+0.96%)

LYEL Lyell Immunopharma
$9.46 /

+0.09 (+0.96%)

Earnings
Zillow raises Q4 Homes segment revenue view to $2.3B-$2.9B from $1.7B-$2.1B » 16:13
12/02/21
12/02
16:13
12/02/21
16:13
Z

Zillow

$54.24 /

+1.2 (+2.26%)

Zillow Group announced it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
Z Zillow
$54.24 /

+1.2 (+2.26%)

Z Zillow
$54.24 /

+1.2 (+2.26%)

11/22/21 Piper Sandler
October housing data positive for Redfin and Zillow, says Piper Sandler
11/19/21 Piper Sandler
Zillow Group price target lowered to $68 from $78 at Piper Sandler
11/04/21 Citi
Citi downgrades Zillow with shares in 'penalty box' on homes exit
11/03/21 Craig-Hallum
Zillow Group price target lowered to $95 from $135 at Craig-Hallum
Z Zillow
$54.24 /

+1.2 (+2.26%)

Z Zillow
$54.24 /

+1.2 (+2.26%)

Z Zillow
$54.24 /

+1.2 (+2.26%)

Z Zillow
$54.24 /

+1.2 (+2.26%)

Earnings
Ulta Beauty raises FY21 EPS view to $16.70-$17.10, consensus $15.19 » 16:13
12/02/21
12/02
16:13
12/02/21
16:13
ULTA

Ulta Beauty

$381.60 /

+11.27 (+3.04%)

Raises FY21 revenue view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ULTA Ulta Beauty
$381.60 /

+11.27 (+3.04%)

ULTA Ulta Beauty
$381.60 /

+11.27 (+3.04%)

10/20/21 Cowen
Ulta Beauty price target lowered to $440 from $490 at Cowen
10/20/21 BofA
Ulta Beauty price target lowered to $400 from $430 at BofA
10/20/21 William Blair
Ulta Beauty should be bought on yesterday's selloff, says William Blair
10/20/21 Baird
Ulta Beauty risk/reward attractive at current levels, says Baird
ULTA Ulta Beauty
$381.60 /

+11.27 (+3.04%)

ULTA Ulta Beauty
$381.60 /

+11.27 (+3.04%)

ULTA Ulta Beauty
$381.60 /

+11.27 (+3.04%)

ULTA Ulta Beauty
$381.60 /

+11.27 (+3.04%)

Hot Stocks
Federal Realty announces holding company reorganization » 16:13
12/02/21
12/02
16:13
12/02/21
16:13
FRT

Federal Realty

$127.24 /

+5.965 (+4.92%)

Federal Realty Investment…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FRT Federal Realty
$127.24 /

+5.965 (+4.92%)

FRT Federal Realty
$127.24 /

+5.965 (+4.92%)

12/01/21 BMO Capital
Federal Realty upgraded to Outperform from Market Perform at BMO Capital
10/06/21 Deutsche Bank
Federal Realty price target raised to $140 from $129 at Deutsche Bank
09/01/21 Barclays
Federal Realty initiated with an Overweight at Barclays
08/27/21 Truist
Federal Realty price target raised to $125 from $120 at Truist
FRT Federal Realty
$127.24 /

+5.965 (+4.92%)

FRT Federal Realty
$127.24 /

+5.965 (+4.92%)

Hot Stocks
Phillips 66, British Airways announces 'sustainable aviation fuel supply deal' » 16:12
12/02/21
12/02
16:12
12/02/21
16:12
PSX

Phillips 66

$71.36 /

+2.65 (+3.86%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PSX Phillips 66
$71.36 /

+2.65 (+3.86%)

PSX Phillips 66
$71.36 /

+2.65 (+3.86%)

11/15/21 Wells Fargo
Phillips 66 price target raised to $104 from $97 at Wells Fargo
11/03/21 Goldman Sachs
Phillips 66 upgraded to Conviction Buy from Buy at Goldman Sachs
11/01/21 Raymond James
Phillips 66 Partners downgraded to Market Perform from Outperform at Raymond James
10/28/21 Credit Suisse
Credit Suisse cuts Phillips 66 Partners to Neutral on acquisition announcement
PSX Phillips 66
$71.36 /

+2.65 (+3.86%)

PSX Phillips 66
$71.36 /

+2.65 (+3.86%)

PSX Phillips 66
$71.36 /

+2.65 (+3.86%)

PSX Phillips 66
$71.36 /

+2.65 (+3.86%)

Hot Stocks
CTO Realty Growth acquires Beaver Creek Crossing in North Carolina for $70.5M » 16:12
12/02/21
12/02
16:12
12/02/21
16:12
CTO

CTO Realty Growth

$55.54 /

+0.97 (+1.78%)

CTO Realty Growth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTO CTO Realty Growth
$55.54 /

+0.97 (+1.78%)

CTO CTO Realty Growth
$55.54 /

+0.97 (+1.78%)

05/28/21 BTIG
CTO Realty Growth initiated with a Buy at BTIG
05/03/21 Compass Point
CTO Realty Growth downgraded to Neutral from Buy at Compass Point
02/23/21 B. Riley Securities
CTO Realty Growth price target lowered to $65 from $67 at B. Riley Securities
Hot Stocks
Ollie's Bargain Outlet announces additional $200M to repurchase » 16:12
12/02/21
12/02
16:12
12/02/21
16:12
OLLI

Ollie's Bargain Outlet

$62.58 /

+1.43 (+2.34%)

During the third quarter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OLLI Ollie's Bargain Outlet
$62.58 /

+1.43 (+2.34%)

OLLI Ollie's Bargain Outlet
$62.58 /

+1.43 (+2.34%)

09/08/21
Fly Intel: Top five analyst upgrades
09/08/21 Berenberg
Ollie's Bargain Outlet upgraded to Buy on pullback at Berenberg
09/08/21 Berenberg
Ollie's Bargain Outlet upgraded to Buy from Hold at Berenberg
09/02/21 Piper Sandler
Ollie's shares attractive at current levels, says Piper Sandler
OLLI Ollie's Bargain Outlet
$62.58 /

+1.43 (+2.34%)

OLLI Ollie's Bargain Outlet
$62.58 /

+1.43 (+2.34%)

OLLI Ollie's Bargain Outlet
$62.58 /

+1.43 (+2.34%)

Earnings
DocuSign sees FY21 revenue $2.083B-$2.089B, consensus $2.09B » 16:11
12/02/21
12/02
16:11
12/02/21
16:11
DOCU

DocuSign

$234.11 /

+3.05 (+1.32%)

Sees FY21 subscription…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DOCU DocuSign
$234.11 /

+3.05 (+1.32%)

DOCU DocuSign
$234.11 /

+3.05 (+1.32%)

10/06/21
DocuSign participates in a conference call with Benchmark
10/06/21
DocuSign participates in a conference call with Benchmark
09/03/21 Evercore ISI
DocuSign price target raised to $320 from $285 at Evercore ISI
09/03/21 Needham
DocuSign price target raised to $340 from $275 at Needham
DOCU DocuSign
$234.11 /

+3.05 (+1.32%)

DOCU DocuSign
$234.11 /

+3.05 (+1.32%)

DOCU DocuSign
$234.11 /

+3.05 (+1.32%)

DOCU DocuSign
$234.11 /

+3.05 (+1.32%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.